{"disease":{"id":"ascvd","name":"ascvd"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07141914","title":"A Master Protocol for Semaglutide Effects on Cardiovascular and Obesity-related Outcomes in People With Overweight or Obesity in the Real World","phase":"","overall_status":"COMPLETED","enrollment_count":285327,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT07417618","title":"INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":60000,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT06295861","title":"Prospective Cohort Study of Panvascular Disease","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":50000,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT06874751","title":"Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity in the Real World","phase":"","overall_status":"COMPLETED","enrollment_count":45456,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT07522645","title":"Adherence to Dyslipidemia Therapy: Harnessing Evidence From Randomized Evaluations in AtheroSclerotic CardioVascular Disease","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":22000,"lead_sponsor_name":"Kaiser Permanente","has_results":false},{"nct_id":"NCT07196280","title":"Protective Effect of 5-Alpha Reductase Inhibitors on Atherosclerotic Cardiovascular Disease in Populations With BPH: Evidence From UK Biobank Cohort and Chinese Single Center Database Studies","phase":"","overall_status":"COMPLETED","enrollment_count":10000,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT05390892","title":"PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":6000,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT02993120","title":"Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD) a Registry of High Cardiovascular Risk Subjects in the United States","phase":"","overall_status":"COMPLETED","enrollment_count":5006,"lead_sponsor_name":"Amgen","has_results":false},{"nct_id":"NCT05579626","title":"Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE-DM)","phase":"PHASE4","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":4000,"lead_sponsor_name":"Seung-Whan Lee, M.D., Ph.D.","has_results":false},{"nct_id":"NCT03814187","title":"Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3275,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT07270887","title":"The Long-term Effect of Remote Ischemic Conditioning on Main Organs in ASVCD Patients With Very High Risks","phase":"","overall_status":"RECRUITING","enrollment_count":2800,"lead_sponsor_name":"General Hospital of Shenyang Military Region","has_results":false},{"nct_id":"NCT06767774","title":"Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Korea University Anam Hospital","has_results":false},{"nct_id":"NCT03400800","title":"Inclisiran for Subjects With ASCVD or ASCVD-Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1617,"lead_sponsor_name":"The Medicines Company","has_results":true},{"nct_id":"NCT03399370","title":"Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1561,"lead_sponsor_name":"The Medicines Company","has_results":true},{"nct_id":"NCT06589791","title":"A Disease Area Study on the Awareness and Perceptions of Systemic Inflammation and hsCRP as a biomARKer in Patients With ASCVD and CKD in China Among Cardiologists and Nephrologists","phase":"","overall_status":"COMPLETED","enrollment_count":1500,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT07464574","title":"Optimizing Non-statin Agents for ASCVD","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"University of Texas at Austin","has_results":false},{"nct_id":"NCT07491978","title":"Development and Multicenter Validation of an AI-Based Remote Photoplethysmography (rPPG) Facial Scan for Multimodal Health Assessment","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Tarumanagara University","has_results":false},{"nct_id":"NCT04197453","title":"The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS)","phase":"","overall_status":"TERMINATED","enrollment_count":752,"lead_sponsor_name":"Amgen","has_results":false},{"nct_id":"NCT07208331","title":"Evaluation of an Integrated, Digital, Nurse-led, Remote Monitoring Care Pathway for Cardiovascular Risk Management","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":750,"lead_sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","has_results":false},{"nct_id":"NCT05976893","title":"Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":620,"lead_sponsor_name":"Xiang Xie","has_results":false},{"nct_id":"NCT05755373","title":"A Multinational Survey-based Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Cardiologists","phase":"","overall_status":"COMPLETED","enrollment_count":602,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT06960902","title":"Study of the Determinants of Coronary Atherosclerosis in Familial Hypercholesterolemia (ATHERO-FH Study)","phase":"NA","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT06005597","title":"Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":407,"lead_sponsor_name":"NewAmsterdam Pharma","has_results":true},{"nct_id":"NCT05088759","title":"Randomized Controlled Trial of Alert-Based Computerized Decision Support for Optimizing Low-Density Lipoprotein Management","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT06471036","title":"Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a Cardiac Event by Providing Education to Doctors and Patients?","phase":"NA","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT06813911","title":"Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":340,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT06322641","title":"A Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Nephrologists","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT06960655","title":"Improving Lipid Optimization Quality and Treatment Options in ASCVD","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":300,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT03494270","title":"High-intensity Rosuvastatin and Moderate-intensity Rosuvastatin/Ezetimibe in ASCVD Patients","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":270,"lead_sponsor_name":"Yuhan Corporation","has_results":false},{"nct_id":"NCT03606824","title":"Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD (ThyroHeart-Lipid Study)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":248,"lead_sponsor_name":"Shaochun.Li","has_results":false},{"nct_id":"NCT06551701","title":"ACHIEVE Pilot Statins for Vascular Protection","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":225,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT07117695","title":"Duke Cardiometabolic Prevention Clinic's Impact on High-risk Cardiovascular Patients With Uncontrolled Risk Factors","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT02957604","title":"Evolocumab Pregnancy Exposure Registry","phase":"","overall_status":"TERMINATED","enrollment_count":140,"lead_sponsor_name":"Amgen","has_results":false},{"nct_id":"NCT06691217","title":"Effects of IL-1 Beta Inhibition on Vascular Inflammation in TET2 Clonal Hematopoiesis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT07315997","title":"The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT03474562","title":"High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Yuhan Corporation","has_results":false},{"nct_id":"NCT05091073","title":"A Research Study Looking at the Effect of Food Intake on How the Medicine NN0385-0434 Behaves in the Body of Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":73,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT07311330","title":"Phase IIa Clinical Trial of YN001 in Patients With Atherosclerotic Cardiovascular and Cerebrovascular Diseases and Erectile Dysfunction","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Beijing Inno Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT05611307","title":"Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors","phase":"","overall_status":"TERMINATED","enrollment_count":31,"lead_sponsor_name":"Indiana University","has_results":false},{"nct_id":"NCT06404515","title":"Telehealth Group Counseling and Preventive Care for Women","phase":"NA","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":false},{"nct_id":"NCT05834673","title":"VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN)","phase":"NA","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"Monash University","has_results":false},{"nct_id":"NCT07000695","title":"Managed Access Programs for TQJ230, Pelacarsen","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false}],"total":42},"guidelines":[],"source":"Drug Landscape verified database"}